Clinical studies recruiting near Derby

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Royal Derby Hospital · Walden Biosciences · NCT06466135 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Royal Derby Hospital · CellCentric Ltd. · NCT04068597 Biological Matrices Versus Synthetic Meshes
NA · University Hospitals of Derby and Burton NHS Foundation Trus · University Hospitals of Derby and Burton NHS Foundation Trus · NCT05449691 PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
Phase N/A · VCTC · Inozyme Pharma · NCT06302439 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Royal Derby Hospital · University College, London · NCT05604963 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Smilow Cancer Hospital-Derby Care Center · SWOG Cancer Research Network · NCT06769126 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital-Derby Care Center · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital-Derby Care Center · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Royal Derby Hospital · Pfizer · NCT06629779 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital-Derby Care Center · SWOG Cancer Research Network · NCT05806515 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Integrity Clinical Network, LLC · Pfizer · NCT07629440 Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Smilow Cancer Hospital-Derby Care Center · National Cancer Institute (NCI) · NCT06649812 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Crystalys Therapeutics · NCT07089888 Postoperative Electrical Muscle Stimulation Two
NA · Royal Derby Hospital · University of Nottingham · NCT06964438 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital-Derby Care Center · National Cancer Institute (NCI) · NCT05256225 Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · Royal Derby Hospital, University Hospitals of Derby and Burt · University of Leeds · NCT04102930 Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity
NA · University Hospitals of Derby and Burton NHS Foundation Trus · Carsten Dirksen · NCT06321458 Characterising the Neuromuscular Function of Post Stroke Patients
Phase N/A · Royal Derby Hospital branch, School of Medicine, University · University of Nottingham · NCT07013188 Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Phase 2 · University Hospitals of Derby and Burton NHS Foundation Trus · University of Southampton · NCT05965479 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Smilow Cancer Hospital-Derby Care Center · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital-Derby Care Center · NRG Oncology · NCT04852887 Remote Ischaemic Conditioning in the Older Person and Effects on Dynamic Cerebral Autoregulation
NA · School of Medicine, University of Nottingham, Royal Derby Ho · University of Nottingham · NCT07179887 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Derby City General Hospital · Boehringer Ingelheim · NCT06632457 A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · Crystalys Therapeutics · NCT07089875 The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Car
Phase N/A · University Hospitals Derby and Burton · Royal Marsden NHS Foundation Trust · NCT05808920 Effects of a Second-generation Mindfulness-based Intervention on Quality of Life, Pain Management, and Psycho-spiritual
NA · University of Derby · University of Derby · NCT06695234 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital-Derby Care Center · National Cancer Institute (NCI) · NCT06058377 Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · University Hospitals of Derby and Burton · The University of Queensland · NCT03573089 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Smilow Cancer Hospital-Derby Care Center · ECOG-ACRIN Cancer Research Group · NCT04239573

Look up another city

Look up another condition